Bharat Biotech to conduct clinical trials for Covaxin in US, Canada
Jun 14, 2021, at 02:31 am
Hyderabad/IBNS: Bharat Biotech will conduct clinical trials for Covaxin in United States and Canada as its US partner Ocugen has said that it will apply for a full licence in the United States for the India-made vaccine.
Covaxin: Bharat Biotech shares full data of all research studies
Jun 12, 2021, at 11:14 pm
Hyderabad/UNI: Demonstrating its scientific commitment to data generation and data transparency, Bharat Biotech shared full data of all research studies of its Covaxin, India’s first indigenous COVID-19 vaccine.
May 26, 2021, at 05:44 am
Hyderabad/IBNS: Amid travel fears that students receiving Covaxin may not be allowed in many countries as the vaccine is not listed, Hyderabad-based pharma major Bharat Biotech on Tuesday said regulatory approvals for its indigenously developed Covid-19 vaccine are in process in more than 60 countries including the US, Brazil and Hungary.
Pediatric trials of Covaxin likely from Jun 1: Dr Raches Ella
May 23, 2021, at 09:19 pm
Hyderabad/UNI: Dr Raches Ella, Head-Business Development & International Advocacy of Bharath Biotech said that the company has received permission to carry out pediatric trials of the Covaxin and it may commence trials from June 1.
Bharat Biotech ramps up Covaxin production by 200 million doses
May 21, 2021, at 05:00 am
New Delhi/IBNS: Bharat Biotech on Thursday said it is gearing up to increase manufacturing capacity of Covaxin by 200 million doses per year.
Bharat Biotech to start Covaxin trials in 2-18 age grp in next 10-12 days: Niti Aayog member
May 19, 2021, at 02:13 am
New Delhi/IBNS: Bharat Biotech will launch the phase II and III clinical trials for Covaxin in children between the ages of 2 to 18 years in the next 10-12 days, Dr VK Paul, member (health) of Niti Aayog, said on Tuesday.
Centre, Bharat Biotech invite vaccine makers to manufacture Covaxin to scale up production
May 14, 2021, at 04:21 am
New Delhi/IBNS: The central government and Hyderabad-based pharmaceutical company Bharat Biotech are willing to invite other companies which want to produce Covaxin to help meet the shortage in production, a top government advisor said on Thursday.
Indian drug regulator DGCI clears Covaxin phase 2, 3 clinical trials for children
May 13, 2021, at 05:08 pm
New Delhi/IBNS: India's drug regulator body has cleared the second and third phase of clinical trials of indigenous anti-Covid-19 vaccine, Covaxin, for children, media reports said.
No Covaxin doses for 18-44 years in Delhi from tomorrow
May 13, 2021, at 05:21 am
New Delhi/IBNS: People between the age group of 18-44 years will not get Covaxin doses in Delhi from Thursday as there is no stock of the Bharat Biotech developed vaccine left in the national capital.
Covaxin supplied to 18 states directly since May 1: Bharat Biotech
May 12, 2021, at 05:24 am
New Delhi/IBNS: Vaccine maker Bharat Biotech on Tuesday informed that it has directly supplied Covaxin to 18 states since May 1.
Bharat Biotech cuts down Covaxin's price for states
Apr 30, 2021, at 01:55 am
Hyderabad/IBNS: Bharat Biotech has reduced the price of Covaxin from Rs 600 per dose to Rs 400 for the state governments in view of the challenges faced by the already overstretched health system, the company said on Thursday.
Apr 29, 2021, at 05:08 am
New Delhi/IBNS: Covaxin, developed by Hyderabad-based Bharat Biotech, ICMR and National Institue of Virology, has been found to protect against the B.1.617 variant or the Indian double mutant strain, said White House Chief Medical Adviser Anthony Fauci on Tuesday.
Apr 17, 2021, at 05:55 am
New Delhi/IBNS: Amid the steep rise in Covid-19 cases, the Centre on Friday said it is taking steps to increase and accelerate the production of indigenous vaccines under Atma Nirbhar Bharat 3.0 Mission COVID Suraksha.
Brazil denies permission to import Bharat Biotech developed Covaxin
Apr 01, 2021, at 04:41 am
New Delhi/IBNS: Brazil's health regulator has denied permission to import Covaxin, the coronavirus vaccine developed by India's indigenous firm Bharat Biotech.
Covaxin taken off clinical trial mode, no consent forms required
Mar 12, 2021, at 03:38 am
New Delhi/IBNS: Pharmaceutical company Bharat Biotech's indigenous Coronavirus vaccine-Covaxin-has been taken off the clinical trial mode, which means beneficiaries will not have to sign consent forms before taking the drug.
COVAXIN is 81 pct effective: Bharat Biotech
Mar 04, 2021, at 12:11 am
Hyderabad: Bharat Biotech, a global leader in vaccine innovation,developing vaccines for infectious diseases, today announced the first interim analysis of itsBBV152 (COVAXIN) where it showed it was 81 percent effective.
Covid-19 vaccination drive starts in Assam
Jan 16, 2021, at 05:44 pm
Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.
Congress MP Manish Tewari questions roll out of Covaxin
Jan 14, 2021, at 01:29 am
New Delhi/IBNS: Congress leader Manish Tewari has raised questions over unavailability of options in choosing the Coronavirus vaccine, according to media reports.
Covid-19: Bharat Biotech rolls out India's indigenous vaccine Covaxin
Jan 13, 2021, at 05:40 pm
Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.
Bharat Biotech announces completion of phase 3 clinical trials of Covid-19 vaccine
Jan 08, 2021, at 12:03 am
New Delhi/UNI: Bharat Biotech on Thursday announced that it has enrolled 25,800 volunteers for phase 3 clinical trials of its indigenously manufactured Covid-19 vaccine, 'Covaxin'.
Jan 05, 2021, at 03:37 am
New Delhi/IBNS: Chairman of Bharat Biotech- whose coronavirus vaccine Covaxin has been permitted for "restricted use in an emergency situation in public interest"- on Monday hit out at its critics and said 'don't accuse us of inexperience.'
Expert panel recommends approval for Bharat Biotech's Covaxin
Jan 03, 2021, at 06:10 am
New Delhi/IBNS: A government-appointed panel of experts on Saturday cleared emergency use of indigenous COVID-19 vaccine Covaxin manufactured by Hyderabad-based Bharat Biotech, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).
Govt's expert panel clears Oxford COVID-19 vaccine for India
Jan 02, 2021, at 03:56 am
New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).
Govt's expert panel to meet over Covid-19 vaccine approval today
Jan 01, 2021, at 04:30 pm
New Delhi/IBNS: An expert panel, appointed by the central government, will on Friday meet over the approval for an emergency use of three Covid-19 vaccines, including an indigenous one.
After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin
Dec 08, 2020, at 04:41 am
New Delhi/IBNS: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical company Bharat Biotech has sought approval from the Drug Controller General of India (DCGI) for the emergency use authorisation (EUA) of its Covid-19 vaccine-Covaxin, media reports said.
India's Covid-19 vaccine candidate 'Covaxin' gets clearance for Phase 3 clinical trials
Oct 23, 2020, at 04:24 am
New Delhi/IBNS: In a ray of hope, India's coronavirus vaccine named 'Covaxin', being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
Bharat Biotech's vaccine candidate shows 'robust immune responses' in animal study
Sep 13, 2020, at 04:38 am
New Delhi/IBNS: Bharat Biotech that has been working on coronavirus vaccine COVAXIN has said a study on animals has shown that the vaccine candidate has helped develop a strong immune response to the highly infectious pathogen.
First phase trial of India's COVID-19 vaccine Covaxin begins on 375 people: Report
Jul 18, 2020, at 03:10 pm
New Delhi: India's Bharat Biotech International Limited, which claimed to have created the country's first potential indigenous coronavirus disease (Covid-19) vaccine, has said the first phase of testing it on 375 people has started, media reports said.
'Process as per global norms': ICMR defends Aug 15 deadline for COVAXIN
Jul 04, 2020, at 11:27 pm
New Delhi/IBNS: The Indian Council of Medical Research (ICMR) has defended the August 15 launch of COVAXIN, after the scientific community of the country termed the short timeline "risky" and "impossible", a media report said.
India aims to launch indigenous Covid-19 vaccine by Aug 15 with ICMR partnering with Bharat Biotech
Jul 03, 2020, at 02:09 pm
New Delhi/IBNS: The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to fast-track the clinical trials of Covid-19 vaccine, giving India a chance to come up with its indigenous cure for the deadly virus, media reports said.